Safety of Oral JAK Inhibitors in Inflammatory Skin Diseases: A Systematic Review and Meta-Analysis of 43 Real-World Studies
1. Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
2. Key Laboratory of Evidence Based Medicine of Gansu Province, Lanzhou, China
3. Institute of Health Data Science, Lanzhou University, Lanzhou, China
4. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
5. Department of Dermatology, The First Hospital of China Medical University, Shenyang, China
6. School of Public Health, Lanzhou University, Lanzhou, China
7. The First School of Clinical Medicine, Lanzhou University, Lanzhou, China
8. School of Intelligent Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
9. Lanzhou University, an Affiliate of the Cochrane China Network, Lanzhou, China
10. WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou, China
chevidence@lzu.edu.cn
gaobarry@hotmail.com
Show less
PDF
